2024 Annual Updates in Hematology Symposium
The 2024 Annual Updates in Hematology Symposium is designed to provide hematology and oncology providers with a state-of-the-art update on hematologic malignancies and blood disorders. It will tackle the latest scientific updates, innovative ideas, and timeliest questions related to the management and care of these challenging conditions. It is also designed to provide a networking opportunity for healthcare professionals, who care for patients with blood cancers and disorders in the Mid-South, to establish collaborative pathways to improve the management and outcomes of this patient population.
- Primary care physicians
- Medical Oncologists
- Nurse practitioners
- Fellows, Residents, Medical students
- Other healthcare professionals dedicated to treating hematologic cancers and disorders
- Identify guidelines to plan and implement individualized treatment decisions for patients with select blood cancers and disorders by leveraging data from molecular and genetic updates.
- Evaluate the latest evidence-based data from clinical trials for emerging therapeutic strategies for select blood cancers and disorders.
- Discuss best strategies in managing treatment-related adverse events through agent familiarity and robust monitoring efforts.
The goal of the 2024 Annual Updates in Hematology Symposium is to provide participants with information to improve patient management and care strategies. This goal will be accomplished by discussing rapidly evolving developments and improved practice paradigms. The symposium will provide learners with enhanced knowledge of evidence-based data related to best practices for treating select blood cancers and disorders and inform them of the indications to refer patients for expert quaternary-level care. Panel discussions, along with question-and-answer sessions that include collaborative sharing of information and research, as well as networking with other healthcare professionals have shown to improve participant knowledge and competency. Additionally, it will build a connected community of hematological care providers across the region.
Parking is available in the following two garages:
- Hamilton Eye Institute Parking Garage (H Lot)
- GEB Parking Garage (E Lot)
AMA Credit Designation:
The University of Tennessee College of Medicine (UTCOM) designates this live activity for a maximum of 3.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Education for Non-Physicians:
The UTCOM will issue Certificates of Participation to non-physicians for participating in this activity and designates it for CEUs using the national standard that 1 hour of educational instruction is awarded .1 CEU.
The UTCOM is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
- 3.25 AMA PRA Category 1 Credit™
- 3.25 Attendance